Inhibition of phagocytic recognition of anti-D opsonized Rh D+ RBC by polymer-mediated immunocamouflage

American Journal of Hematology

Volumn 90, Issue 12, 2015, Pages 1165-1170

  Li, Li ^a,b   Noumsi, Ghislain T ^c,d   Kwok, Yin Yu Eunice ^b   Moulds, Joann M ^c,d   Scott, Mark D ^a,b  

^a CANADIAN BLOOD SERVICES   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c LifeShare Blood Centers   (United States)

^d Grifols ImmunoHematology Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; FRESH FROZEN PLASMA; IMMUNOGLOBULIN G3; POLYMER; RHESUS D ANTIBODY; OPSONIN; RHO(D) ANTIBODY;

ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; BIOLOGICAL MIMICRY; BLOOD TRANSFUSION REACTION; CELL INTERACTION; CELL MEMBRANE; CONTROLLED STUDY; COOMBS TEST; ELECTROPHORETIC MOBILITY; ERYTHROPHAGOCYTOSIS; FLOW CYTOMETRY; IMMUNE SYSTEM; MACROPHAGE; MONOCYTE; OPSONIZATION; PRIORITY JOURNAL; ERYTHROCYTE TRANSFUSION; HUMAN; IMMUNOLOGY; METABOLISM; PHAGOCYTE; PROCEDURES;

ERYTHROCYTE TRANSFUSION; HUMANS; ISOANTIBODIES; OPSONIN PROTEINS; PHAGOCYTES; POLYMERS; RHO(D) IMMUNE GLOBULIN;

EID: 84954372619     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.24211     Document Type: Article

References (41)

1. Dodd R, Kurt Roth W, Ashford P, et al. Transfusion medicine and safety. Biologicals 2009;37:62-70.
2. Kleinman S, Chan P, Robillard P. Risks associated with transfusion of cellular blood components in Canada. Transfus Med Rev 2003;17:120-162.
3. Murphy MF, Stanworth SJ, Yazer M. Transfusion practice and safety: Current status and possibilities for improvement. Vox Sang 2011;100:46-59.
4. Castro O, Sandler SG, Houston-Yu P, Rana S. Predicting the effect of transfusing only phenotype-matched RBCs to patients with sickle cell disease: Theoretical and practical implications. Transfusion 2002;42:684-690.
5. Cheng CK, Lee CK, Lin CK. Clinically significant red blood cell antibodies in chronically transfused patients: A survey of Chinese thalassemia major patients and literature review. Transfusion 2012;52:2220-2224.
6. Chou ST, Jackson T, Vege S, et al. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 2013;122:1062-1071.
7. Matteocci A, Pierelli L. Red blood cell alloimmunization in sickle cell disease and in thalassaemia: Current status, future perspectives and potential role of molecular typing. Vox Sang 2014;106:197-208.
8. O'Suoji C, Liem RI, Mack AK, et al. Alloimmunization in sickle cell anemia in the era of extended red cell typing. Pediatr Blood Cancer 2013;60:1487-1491.
9. Singer ST, Wu V, Mignacca R, et al. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly asian descent. Blood 2000;96:3369-3373.
10. Vichinsky EP, Luban NL, Wright E, et al. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: A multicenter transfusion trial. Transfusion 2001;41:1086-1092.
11. Mourant AE, Kopec AC, Domaniewski-Sobczak K. Blood Groups and Disease. London: Oxford University Press; 1978.
12. Reid ME, Lomas-Francis C. The Blood Group Antigen Facts Book. San Diego: Academic Press; 2003.
13. Williamson LM, Devine DV. Challenges in the management of the blood supply. Lancet 2013;381:1866-1875.
14. Flegel WA. Molecular genetics and clinical applications for RH. Transfus Apher Sci 2011;44:81-91.
15. Iwamoto S. Molecular aspects of Rh antigens. Leg Med (Tokyo) 2005;7:270-273.
16. Lan JC, Chen Q, Wu DL, et al. Genetic polymorphism of RhD-negative associated haplotypes in the Chinese. J Hum Genet 2000;45:224-227.
17. Urbaniak SJ. Alloimmunity to RhD in humans. Transfus Clin Biol 2006;13:19-22.
18. Scott MD, Murad KL, Koumpouras F, et al. Chemical camouflage of antigenic determinants: Stealth erythrocytes. Proc Natl Acad Sci U S A 1997;94:7566-7571.
19. Murad KL, Mahany KL, Brugnara C, et al. Structural and functional consequences of antigenic modulation of red blood cells with methoxypoly(ethylene glycol). Blood 1999;93:2121-2127.
20. Scott MD, Bradley AJ, Murad KL. Camouflaged blood cells: Low-technology bioengineering for transfusion medicine? Transfus Med Rev 2000;14:53-63.
21. Bradley AJ, Test ST, Murad KL, et al. Interactions of IgM ABO antibodies and complement with methoxy-PEG-modified human RBCs. Transfusion 2001;41:1225-1233.
22. Bradley AJ, Murad KL, Regan KL, Scott MD. Biophysical consequences of linker chemistry and polymer size on stealth erythrocytes: Size does matter. Biochim Biophys Acta 2002;1561:147-158.
23. Bradley AJ, Scott MD. Immune complex binding by immunocamouflaged [poly(ethylene glycol)-grafted] erythrocytes. Am J Hematol 2007;82:970-975.
24. Le Y, Scott MD. Immunocamouflage: The biophysical basis of immunoprotection by grafted methoxypoly(ethylene glycol) (mPEG). Acta Biomater 2010;6:2631-2641.
25. Wang D, Kyluik DL, Murad KL, et al. Polymer-mediated immunocamouflage of red blood cells: Effects of polymer size on antigenic and immunogenic recognition of allogeneic donor blood cells. Sci China Life Sci 2011;54:589-598.
26. Wang D, Toyofuku WM, Scott MD. The potential utility of methoxypoly(ethylene glycol)-mediated prevention of rhesus blood group antigen RhD recognition in transfusion medicine. Biomaterials 2012;33:3002-3012.
27. Le Y, Li L, Wang D, Scott MD. Immunocamouflage of latex surfaces by grafted methoxypoly(ethylene glycol) (mPEG): Proteomic analysis of plasma protein adsorption. Sci China Life Sci 2012;55:191-201.
28. Kyluik-Price DL, Li L, Scott MD. Comparative efficacy of blood cell immunocamouflage by membrane grafting of methoxypoly(ethylene glycol) and polyethyloxazoline. Biomaterials 2014;35:412-422.
29. Branch DR, Gallagher MT, Mison AP, et al. In vitro determination of red cell alloantibody significance using an assay of monocyte-macrophage interaction with sensitized erythrocytes. Br J Haematol 1984;56:19-29.
30. Branch DR, Gallahger MT. Correlation of in vivo alloantibody significance or insignificance with an in vitro monocyte-macrophage phagocytosis assay. Br J Haematol 1986;62:783-785.
31. Garratty G. Predicting the clinical significance of red cell antibodies with in vitro cellular assays. Transfus Med Rev 1990;4:297-312.
32. Noumsi GT, Billingsley KL, Moulds JM. Successful transfusion of antigen positive blood to alloimmunised patients using a monocyte monolayer assay. Transfus Med 2015;25:92-100.
33. Arndt PA, Garratty G. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies. Transfusion 2004;44:1273-1281.
34. Karamatic Crew V, Poole J, Long S, et al. Two MER2-negative individuals with the same novel CD151 mutation and evidence for clinical significance of anti-MER2. Transfusion 2008;48:1912-1916.
35. Nance SJ, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449-452.
36. Rampersad GC, Suck G, Sakac D, et al. Chemical compounds that target thiol-disulfide groups on mononuclear phagocytes inhibit immune mediated phagocytosis of red blood cells. Transfusion 2005;45:384-393.
37. Gallagher MT, Branch DR, Mison A, Petz LD. Evaluation of reticuloendothelial function in autoimmune hemolytic anemia using an in vitro assay of monocyte-macrophage interaction with erythrocytes. Exp Hematol 1983;11:82-89.
38. Zupanska B, Thompson E, Brojer E, Merry AH. Phagocytosis of erythrocytes sensitized with known amounts of IgG1 and IgG3 anti-Rh antibodies. Vox Sang 1987;53:96-101.
39. Kyluik-Price DL, Scott MD. Effects of methoxypoly (ethylene glycol) mediated immunocamouflage on leukocyte surface marker detection, cell conjugation, activation and alloproliferation. Biomaterials 2015, doi:10.1016/j.biomaterials.2015.09.047.
40. Scott MD, Murad KL. Cellular camouflage: Fooling the immune system with polymers. Curr Pharm Des 1998;4:423-438.
41. Bradley AJ, Scott MD. Separation and purification of methoxypoly(ethylene glycol) grafted red blood cells via two-phase partitioning. J Chromatogr B Analyt Technol Biomed Life Sci 2004;807:163-168.